What insurance policy changes affect CPT 61863?

There are 12 tracked policy changes affecting CPT 61863, including updates from Aetna, Humana. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for CPT 61863?

Payers that have issued tracked updates for CPT 61863 include: Aetna, Humana.

How do I get notified when CPT 61863 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 61863. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for CPT 61863?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

61863 — Surgically placing an electronic device inside the brain or nervous system to monitor activity or deliver therapeutic stimulation.: Insurance Policy Changes

61863 Insurance Policy Changes

CPT 61863, in plain terms, covers Surgically placing an electronic device inside the brain or nervous system to monitor activity or deliver therapeutic stimulation. CPT 61863 is referenced in 12 tracked payer policy changes from Aetna and Humana. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 61863 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

High impact

Deep Brain Stimulation (CPB 0208, reviewed 2026-03-27)

Aetna·Effective Mar 27, 2026

Aetna updated its Deep Brain Stimulation (DBS) medical policy (CPB 0208, reviewed 2026-03-27) establishing specific medical necessity criteria for DBS implantation across multiple indications including Parkinson's disease tremor, motor complications, dystonia, and refractory epilepsy. The policy defines required patient screening criteria, procedural codes covered when criteria are met, and clearly identifies experimental/investigational uses that will not be covered. Billing teams must ensure prior authorization reviews confirm all medical necessity criteria are documented before submitting DBS implantation and related procedure claims.

61863 Insurance Policy Changes

Headaches: Invasive Procedures (CPB 0707, reviewed 2026-07-23)

Deep Brain Stimulation (CPB 0208, reviewed 2026-03-27)

Headaches: Invasive Procedures (CPB 0707, reviewed 2026-10-15)

Tourette's Syndrome (CPB 0480, reviewed 2026-07-24)

Tinnitus Treatments (CPB 0406, reviewed 2026-07-10)

Epilepsy Surgery (CPB 0394, reviewed 2026-06-23)

Neurostimulators - MEDICAID - SOUTH CAROLINA (New)

Neurostimulators - MEDICAID - MICHIGAN (New)

Neurostimulators - MEDICAID - INDIANA (New)

Huntington's Disease (CPB 0614, reviewed 2026-02-25)

Alzheimer's Disease: Experimental, Investigational, or Unproven Treatments (CPB 0788, reviewed 2025-11-19)

Huntington's Disease (CPB 0614, reviewed 2026-09-24)